Nanostructured Drug Market 2021 Size, Share, Key Players, Factor Analysis, Segments, Market Dynamics and Regional Forecast to 2027
SEATTLE, April 02, 2021, (PHARMIWEB) — Nanotechnology is an emerging field of science that involves atomic or molecular level manipulation of matter. Nanotechnology find its application in different fields such as chemical sensors, batteries, food, fuel cells, solar cells, fabric, fuels, electronics, space, better air quality, cleaner water, and sporting goods. One of the key application of nanotechnology include medicine, nanomedicine ranges from the medical application such as biological device, nanomaterial, nanoelectronic biosensors, and biological machines. Nanotechnology has exhibited option of drug delivery to specific target cells employing nanoparticles. Particles are engineered to attach to diseases cells, which allows direct treatment of those cells. Drug delivery techniques are designed to reduce side effects associated with the drugs along with decrease in its consumption and treatment costs. Nanostructured drugs have various applications in neurology, cardiovascular/physiology, anti-inflammatory/immunology, anti-infective, and others.
To learn more about this report, request a sample copy*
* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy of this report@ https://www.coherentmarketinsights.com/insight/request-sample/1841
Nanostructured Drug Market Dynamics
Nanostructured drugs are gaining significant traction in research and development due to benefits offered by them in terms of bioavailability, drug stability, shelf-life, and dosage. Effective and safe drug delivery is a major challenge in biotechnology and pharmaceutical manufacturers. Novel techniques such as nanotechnology are introduced by companies to manufacture innovative product, which is expected to drive growth of the nanostructured drug market. For instance, in 2015, the Food and Drug Administration (FDA) approved Onivyde, an irinotecan liposome injection by Merrimack pharmaceuticals, which is a prescription medicine used to treat pancreatic cancer. Onivyde is administered in combination with two other drugs, leucovorin and fluorouracil. Onivyde consists of a chemotherapy drug called irinotecan, which interrupts cell reproduction. Irinotecan is trapped into a nanostructure called liposome. Liposomes are programmed to release drug slowly within the interval of time.
Moreover, increasing funding and revenue from nano-enabled products are expected to propel growth of the nanostructured drug market. For instance, according to the National Science Foundation 2014 market report, global funding for emerging nanotechnology increased by 40% to 45% for past three years. Furthermore, worldwide revenue generated by nano-enabled products increased from US$ 339 billion in 2010 to US$ 731 billion in 2012, and over US$ 1 trillion in 2013.
However, high cost for development of nanostructured drugs and safety risks associated with nanostructured drugs such as the duration of time nanoparticles remain in the body, which affects cellular and tissue functions are expected to hamper the market growth.
Access research reports that are tailored specifically for you and your organization in order to explore practical growth strategies and recommendations
Buy-Now this Research Report @ https://bit.ly/3mfe8VV
Nanostructured Drug Market – Regional Insights
On the basis of region, the global nanostructured drug treatment market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to hold dominant position in the global nanostructured drug market, owing to massive funding by the government for the nanotechnology research. For instance, according to a study led by Lux Research with funding support from U.S. national Foundation and U.S. National Nanotechnology Coordination Office in 2013, around US$ 1.9 billion was funded in 2011 and US$ 2.1 billion in 2012 for nanotechnology research and development (R&D). Moreover, increasing awareness among population about various chronic diseases and well established healthcare infrastructure is expected to propel nanostructured drug market growth over the forecast period.
Asia Pacific is expected to account for a significant market share in the nanostructured drug market, followed by Europe over the forecast period, owing to increasing number of population susceptible to various chronic diseases such cancer, HIV, and tuberculosis. For instance, according to the National Health and Family Planning Commission of the PRC report in 2015, around 533 out of 100,000 people were reported to die from chronic disease in 2012 in China, accounting for 86.6% of all deaths.
Nanostructured Drug Market – Competitive Landscape
The key players operating in the global nanostructured drug market include Nanoviricides Inc., Ablynx NV, Pfizer Inc., Nanotherapeutics Inc., Arrowhead Research Inc., Abraxis Inc., Merck, Bio-Gate AG, and Celgene Corporation.
To understand Research Methodology, please click https://www.coherentmarketinsights.com/ongoing-insight/nanostructured-drug-market-1841
Market players are focused on adopting strategies such as increasing funding, acquisitions, and collaborations to strengthen their product portfolio and to hold dominant position in the market, For instance, in 2016, Pfizer Inc. received bankruptcy-court approval to buy all asserts of Bind Therapeutics a biotechnology company developing targeted and programmable therapeutics (nanomedicine) called ACCURINS.
Nanostructured Drug Market Taxonomy
On the basis of technology, the global nanostructured drug market is segmented into:
On the basis of application, the global nanostructured drug market is segmented into:
On the basis of region, the global nanostructured drug market is segmented into:
- North America
- Latin America
- Asia Pacific
- Middle East
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
- CDN Newswire